Stock & Company Details
BioVie Inc $BIVI
Price:
N/A
N/A
8.7M
$13M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BIVI technical indicators
Latest BioVie Inc (BIVI) indicator readings as of 2026-10-29.
BIVI's 14-day RSI is 48.4, in neutral territory. At $1.38 it is trading 9.0% below its 200-day moving average of $1.52, and below its 50-day average of $1.65. Price sits in the middle of its Bollinger Bands ($1.12 to $1.53). ADX reads 13.1, indicating a range-bound market rather than a trend.
Overview
BioVie Inc is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Finance Bot
Ask your questions
Start by typing a question below.
